Recombinant Human Natural cytotoxicity triggering receptor 2 (NCR2)

What is NCR2 and what alternative nomenclature exists in the literature?

NCR2, also known as CD336, LY95, NK-P44, NKP44, Lymphocyte Antigen 95, and Natural killer cell p44-related protein, is a cytotoxicity-activating receptor expressed on NK cells . It functions as a cell membrane receptor that contributes to the increased efficiency of activated natural killer cells in mediating tumor cell lysis . Understanding the various nomenclatures is essential for comprehensive literature searches, as different research groups may use alternative designations in their publications.

What is the molecular structure and expression region of human NCR2?

Human NCR2 is a membrane protein with an expression region typically spanning from Gln22 to Ser120 . The recombinant form has a theoretical molecular weight of approximately 15 kDa, with SDS-PAGE analysis confirming this predicted size . The protein contains an N-terminal extracellular domain, a transmembrane region with a charged amino acid residue (critical for association with signaling adaptors), and a cytoplasmic domain. The protein's isoelectric point is approximately 8.4, indicating its slightly basic nature in physiological conditions .

How does NCR2 contribute to NK cell activation and immune function?

NCR2 plays a fundamental role in natural killer cell activation by triggering cytotoxicity against target cells. Upon engagement with its ligands, NCR2 initiates signaling cascades that lead to NK cell activation, proliferation, and cytokine production . The receptor contains a transmembrane charged amino acid residue that enables non-covalent association with signaling adaptors like TYROBP (DAP12), which contains immunoreceptor tyrosine-based activation motifs (ITAMs) . This association is crucial for signal transduction, as TYROBP becomes tyrosine-phosphorylated following ligand binding, leading to the recruitment and activation of additional tyrosine kinases and subsequent NK cell activation .

What expression systems are optimal for producing functional recombinant human NCR2?

Prokaryotic expression systems, particularly E. coli, have been successfully employed for the production of recombinant human NCR2 . This approach yields high purity (>95% as confirmed by SDS-PAGE) and functional protein . The recombinant protein typically includes the extracellular domain (Gln22~Ser120) with an N-terminal His-tag to facilitate purification . While prokaryotic systems may lack some post-translational modifications present in native human NCR2, they provide sufficient structural integrity for most research applications, including antibody production, protein-protein interaction studies, and as positive controls in analytical techniques.

What quality control metrics should be considered when evaluating recombinant NCR2?

Key quality control parameters for recombinant NCR2 include purity (>95% by SDS-PAGE), endotoxin levels (<1.0 EU per 1μg as determined by the LAL method), and protein concentration . Additionally, the recombinant protein should demonstrate appropriate molecular weight (approximately 15 kDa) on SDS-PAGE analysis . For functional studies, biological activity assessment through receptor-ligand binding assays or cell-based functional assays should be considered. Researchers should also verify the absence of protein aggregation and confirm proper folding through techniques such as circular dichroism or limited proteolysis.

How do buffer components affect recombinant NCR2 stability and activity?

Recombinant NCR2 is typically formulated in PBS (pH 7.4) containing preservatives such as 0.01% SKL and cryoprotectants like 5% trehalose . These components are critical for maintaining protein stability during storage and freeze-thaw cycles. The pH of the buffer (7.4) is optimized to maintain the native conformation of the protein, while trehalose prevents protein denaturation during freeze-thaw cycles by stabilizing the hydration shell around the protein. When designing experiments, researchers should consider potential buffer effects on downstream applications and may need to dialyze the protein into application-specific buffers while maintaining appropriate pH and ionic strength.

What are the optimal storage conditions for maintaining recombinant NCR2 activity?

For long-term storage, recombinant NCR2 should be stored at -80°C for up to 12 months in aliquots to avoid repeated freeze-thaw cycles . For intermediate storage (up to one month), the protein can be kept at 2-8°C . When supplied as a freeze-dried powder, the protein demonstrates enhanced stability at ambient temperatures for shipping purposes, but should be reconstituted and properly stored upon receipt . Monitoring protein stability through periodic activity assays is recommended for critical experiments, especially when using proteins that have been stored for extended periods.

What reconstitution protocols maximize recombinant NCR2 functionality?

Lyophilized recombinant NCR2 should be reconstituted in 10mM PBS (pH 7.4) to a concentration of 0.1-1.0 mg/mL . It's critical to avoid vortexing during reconstitution as this can lead to protein denaturation and aggregation . Instead, gentle inversion or slow pipetting should be employed to ensure complete dissolution without compromising protein structure. Following reconstitution, the protein solution should be briefly centrifuged to collect any dispersed material and then aliquoted to minimize freeze-thaw cycles if not used immediately.

How can thermal stability of recombinant NCR2 be assessed and optimized?

Thermal stability of recombinant NCR2 can be evaluated by monitoring the loss rate under various temperature conditions . Techniques such as differential scanning fluorimetry (DSF) or circular dichroism (CD) spectroscopy at various temperatures can provide quantitative measures of protein unfolding and denaturation. To optimize thermal stability, researchers can explore buffer additives such as glycerol, trehalose, or specific salts that may enhance protein stability. Additionally, avoiding repeated freeze-thaw cycles is crucial, as each cycle can lead to partial denaturation and decreased activity.

How can recombinant NCR2 be utilized in NK cell activation studies?

Recombinant NCR2 serves as a valuable tool for studying NK cell activation mechanisms. Studies have shown that cross-linking of NCR receptors with specific antibodies or recombinant ligands can induce NK cell activation, leading to CD25 expression, proliferation, and cytokine production . When designing such experiments, researchers can immobilize recombinant NCR2 (10 μg/ml) on plastic surfaces to examine receptor engagement effects on NK cells . Alternatively, soluble recombinant NCR2 can be used to block or stimulate NK cell receptors in functional assays. These approaches help delineate the specific contribution of NCR2 to NK cell activation compared to other receptors like NKG2D.

What techniques are most effective for studying NCR2 protein interactions?

Several approaches can be employed to study NCR2 protein interactions. STRING database analysis indicates strong interactions between NCR2 and TYROBP (score: 0.999), as well as with NCR1 and NCR3 (scores: 0.995) . Co-immunoprecipitation assays using anti-NCR2 antibodies can identify native protein complexes. For in vitro studies, surface plasmon resonance (SPR) or biolayer interferometry using purified recombinant NCR2 can provide quantitative binding kinetics. Additionally, proximity ligation assays (PLA) or fluorescence resonance energy transfer (FRET) techniques can visualize protein interactions in cellular contexts, offering insights into the spatial and temporal dynamics of NCR2 signaling complexes.

How can recombinant NCR2 be utilized in antibody development and validation?

Recombinant NCR2 serves as an excellent immunogen for developing polyclonal and monoclonal antibodies . The high purity (>95%) of recombinant preparations ensures specific immune responses during immunization. For antibody validation, recombinant NCR2 can function as a positive control in techniques such as Western blotting, ELISA, and immunoprecipitation . When developing validation protocols, researchers should include appropriate controls, such as comparing antibody reactivity in NCR2-expressing versus non-expressing cells, and confirming specificity through competitive binding assays with purified recombinant NCR2.

What is known about the transcriptional regulation and alternative splicing of NCR2?

Unlike murine NKG2D, which exhibits alternative splicing to generate variants that associate with different signaling adaptors, similar extensive alternative splicing has not been detected in human NCR2 . Research using rapid amplification of cDNA ends (RLM 5'-RACE) on NK cells identified four distinct transcripts, with the induction of a shorter transcript (transcript 4) correlating with IL-2 stimulation . This suggests that while alternative splicing occurs, it may be regulated by activation state rather than generating functionally distinct receptor variants. Future research directions might include comprehensive RNA-seq analysis of NK cells under various stimulation conditions to fully characterize the transcriptional landscape of NCR2 and identify regulatory elements controlling its expression.

How do NCR2-mediated pathways interact with other NK cell receptor systems to regulate cytotoxicity?

NCR2 functions within a complex network of activating and inhibitory receptors on NK cells. Studies show that both NCR and NKG2D ligands can induce cytokine production (GM-CSF and IFN-γ) by NK cells, though through potentially different mechanistic pathways . The interaction between these receptor systems appears to be context-dependent, with the activation state of NK cells influencing receptor cooperation. For instance, the effects of NCR or NKG2D engagement were detected in polyclonal activated NK cells or NK cells within peripheral blood mononuclear cells (PBMCs), but were not evident using resting purified NK cells . This suggests that receptor cooperativity may depend on the activation threshold of NK cells and potentially on the presence of accessory cells or factors. Future research should focus on elucidating the signaling crosstalk between NCR2 and other receptor systems using techniques such as phosphoproteomics and targeted pathway inhibition.

What approaches can resolve inconsistent results in NCR2-based activation assays?

Inconsistent results in NCR2 activation assays often stem from variations in NK cell activation states. As observed in comparative studies, resting purified NK cells may not respond to NCR triggering in the same way as IL-2 activated NK cells . To standardize experiments, researchers should carefully control NK cell activation status through consistent culture conditions and cytokine treatments. Additionally, dose-response curves should be established for stimulating antibodies or recombinant ligands, as concentration-dependent effects may exhibit threshold behaviors. When using blocking antibodies in specificity controls, ensure complete blocking through titration experiments rather than using a single concentration. Finally, consider the impact of plastic-bound versus soluble stimulation, as the mode of receptor engagement can significantly influence outcomes.

How can researchers overcome challenges in detecting NCR2 protein expression?

Detection of NCR2 can be challenging due to potentially low expression levels in certain cell types or conditions. For flow cytometry applications, signal amplification techniques like biotin-streptavidin systems can enhance detection sensitivity. When performing Western blot analysis, membrane enrichment protocols can concentrate the target protein, improving detection of this membrane-associated receptor. For immunohistochemistry or immunofluorescence, antigen retrieval optimization is crucial, as fixation can mask NCR2 epitopes. Researchers should also consider the specificity of detection antibodies, validating them against known positive controls (activated NK cells) and negative controls (cell lines known not to express NCR2).

What strategies can improve yield and quality in recombinant NCR2 production?

To optimize recombinant NCR2 production, several strategies can be implemented. For E. coli expression systems, codon optimization of the NCR2 sequence for prokaryotic expression can significantly improve protein yields . Expression temperature optimization (typically lower temperatures of 16-25°C) can enhance proper folding and reduce inclusion body formation. For purification, stepwise optimization of imidazole concentrations during His-tag affinity purification can improve purity while maintaining yield. If functional studies require post-translational modifications absent in prokaryotic systems, researchers might consider mammalian or insect cell expression systems, though these typically yield lower protein amounts. Finally, buffer optimization during purification and storage is critical, with the addition of stabilizers like trehalose demonstrating significant improvements in long-term protein stability .